Important Notice regarding Dextenza and Klarity-C

Posted in Latest News on October 15, 2019.

During the September 27, 2019 Board of Optometry meeting, the Board approved Dextenza (dexamethasone ophthalmic insert) 0.4 mg and approved Klarity-C (cyclosporine) 0.1% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Dextenza and Klarity-C cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

The Annual Report and Long-Range Plan Released for Fiscal Year 2020-21
November 1, 2021

The Annual Report and Long-Range Plan for Fiscal Year 2020-21
is now online. Continue reading


Fourth Quarter Performance Report
October 14, 2021

Released for the
2020-21 Fiscal Year Continue reading